- Home
- NCLH vs CORT Comparison
NCLH vs CORT Comparison
Compare NCLH & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NCLH | CORT |
|---|---|---|
| Founded | 1966 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.7B | 7.6B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | NCLH | CORT |
|---|---|---|
| Price | $20.86 | $88.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 5 |
| Target Price | $28.89 | ★ $139.00 |
| AVG Volume (30 Days) | ★ 15.3M | 663.7K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 11.76 | N/A |
| EPS | ★ 1.40 | 0.87 |
| Revenue | ★ $9,692,558,000.00 | $741,172,000.00 |
| Revenue This Year | $6.85 | $23.79 |
| Revenue Next Year | $10.76 | $40.97 |
| P/E Ratio | ★ $14.93 | $99.75 |
| Revenue Growth | 3.59 | ★ 17.92 |
| 52 Week Low | $14.21 | $49.00 |
| 52 Week High | $29.29 | $117.33 |
Technical Indicators
Market Signals| Indicator | NCLH | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 62.86 | 68.54 |
| Support Level | $18.51 | $81.31 |
| Resistance Level | $19.23 | $87.19 |
| Average True Range (ATR) | 0.63 | 2.86 |
| MACD | 0.42 | 0.74 |
| Stochastic Oscillator | 86.83 | 93.81 |
Price Performance
Historical ComparisonAbout NCLH Norwegian Cruise Line Holdings Ltd.
Norwegian Cruise Line is the world's third-largest publicly traded cruise company by berths (around 71,000). It operates 34 ships across three brands—Norwegian, Oceania, and Regent Seven Seas—offering both freestyle and luxury cruising. The company redeployed its entire fleet as of May 2022. With 13 passenger vessels on order among its brands through 2036, representing 38,400 incremental berths, Norwegian is increasing capacity faster than its peers, expanding its brand globally. Norwegian sails to around 700 global destinations.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.